The genetic component of complex disease risk in humans remains largely unexplained. A corollary is that the allelic spectrum of genetic variants contributing to complex disease risk is unknown. Theoretical models that relate population genetic processes to the maintenance of genetic variation for quantitative traits may suggest profitable avenues for future experimental design. Here we use forward simulation to model a genomic region evolving under a balance between recurrent deleterious mutation and Gaussian stabilizing selection. We consider multiple genetic and demographic models, and several different methods for identifying genomic regions harboring variants associated with complex disease risk. We demonstrate that the model of gene action, relating genotype to phenotype, has a qualitative effect on several relevant aspects of the population genetic architecture of a complex trait. In particular, the genetic model impacts genetic variance component partitioning across the allele frequency spectrum and the power of statistical tests.
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showing that the genetic load is approximately unaffected by changes in population size over time, [21, 22] . 73 Consistent with recent work by [23] , we find that rapid population growth in the recent past increases the 74 contribution of rare variants to total genetic variance. However, we show here that different models of gene 75 action are qualitatively different with respect to the partitioning of genetic variance across the allele 76 frequency spectrum. We also show that these conclusions hold under the more complex demographic models 77 that have been proposed for human populations [21, 40] . 78 Results and Discussion 79 The Models 80 As in [36] ,we simulate a 100 kilobase region of human genome, contributing to a complex disease phenotype 81 and fitness. The region evolves forward in time subject to neutral and deleterious mutation, recombination, 82 selection, and drift. To perform genetic association and heritability estimation studies in silico, we need to 83 impose a trait onto simulated individuals. In doing so, we introduce strong assumptions about the molecular 84 underpinnings of a trait and its evolutionary context. 85 How does the molecular genetic basis of a trait under natural selection influence population genetic 86 signatures in the genome? This question is very broad, and therefore it was necessary to restrict ourselves to 87 a small subset of molecular and evolutionary scenarios. We analyzed a set of approaches to modeling a single 88 gene region experiencing recurrent unconditionally-deleterious mutation contributing to a quantitative trait 89 subject to Gaussian stabilizing selection. Specifically, we studied three different genetic models and two 90 different demographic models, holding the fitness model as a constant. Parameters are briefly described in 91 Table 1 . 92 We implemented three disease-trait models of the phenotypic form P = G + E. G is the genetic that controls the degree of recessivity; we call this model the complete MR (cMR) when h = 0 and the 99 incomplete MR (iMR) when 0  h  1. It is important to note that here recessivity is being defined in terms 100 of phenotypic effects; this may be unusual for those more accustomed to dealing directly with recessivity for 101 fitness effects. An idealized relationship between dominance for fitness effects and trait effects of a mutation 102 on an unaffected genetic background is shown in S15 Fig.   103 The critical conceptual difference between recessive models is whether dominance is a property of a locus 104 (nucleotide/SNP) in a gene or the gene overall. Mathematically, this amounts to whether one first determines 105 diploid genotypes at sites (and then multiplies across sites to get a total genetic effect) or calculates a score 106 for each haplotype (the maternal and paternal alleles). For completely co-dominant models, this distinction 107 is irrelevant, however for a model with arbitrary dominance one needs to be more specific. As an example, 108 imagine a compound heterozygote for two biallelic loci, i.e. genotype Ab/aB. In the case of traditional all; this implies that these loci are in different genes (or independent functional units of the same gene) 111 because the mutations are complementary. However, in the case of gene-based recessivity [36] , neither 112 haplotype is wild-type and so the individual is not wild-type; the failure of mutant alleles to complement 113 defines these loci as being in the same gene [35] . 114 For a diploid with m i causative mutations on the i th haplotype, we may define the additive model as
where c i,j is the effect size of the j th mutation on the i th haplotype. Each c i,j is sampled from an 116 exponential distribution with mean of , to reflect unconditionally deleterious mutation. In other words, 117 when a new mutation arises it's effect c is drawn from an exponential distribution, and remains constant 118 throughout it's entire sojourn in the population.
119
The GBR model is the geometric mean of the sum of effect sizes on each haplotype [36] . We sum the 120 causal mutation effects on each allele (paternal and maternal) to obtain a haplotype score. We then take the 121 square root of the product of the haplotype scores to determine the total genetic value of the diploid.
122
Finally, the MR model depends on the number of positions for which a diploid is heterozygous (m Aa ) or 123 homozygous (m aa ) for causative mutations,
Thus, h = 0 is a model of multiplicative epistasis with complete recessivity (cMR), and h = 1 closely 125 approximates the additive model when effect sizes are small.
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Here, phenotypes are subject to Gaussian stabilizing selection with an optimum at zero and standard 127 deviation of s = 1 such that the fitness, w, of a diploid is proportional to a Gaussian function [41] .
The AC and MR models draw no distinction between a "mutation" and a "gene" (as discussed in [36] ). 129
The GBR is also a recessive model, but recessivity is at the level of a haplotype (or allele) and is not an effect of a variant is not independent of other variants (e.g., there is intralocus epistasis). Therefore, we resort 159 to a regression-based approach, where we regress the genotypes of the population onto the total genetic value 160 as defined in our disease trait models (see Material and Methods). In the limit of Hardy-Weinberg and 161 linkage equilibrium, the regression estimates are equivalent to standard quantitative genetic estimates [29] 162 (S14 Fig) . For consistency, we applied the regression approach to all models. Overall, these distributions are 163 substantially different across genetic models, demographic scenarios and model parameters (Fig 1) . growth increases the fraction of additive genetic variation due to rare alleles (Fig 1) . increasing strength of selection, increasing in our work, increases the contribution to heritability of rare 7 variants. However, under the GBR model and the cMR model the distribution of genetic variance over risk 179 allele frequency as function is non-monotonic ( Fig 1 and S4 Fig) .
For all recessive models, we find that total V A is less than V G (Fig 1) . For the MR models, all additional 181 genetic variation is explained by the dominance variance component; in drastically across different modeling approaches. It is therefore necessary to carefully consider the structure 216 of a genetic model in a simulation study.
217
The conclusions reached here also hold when we consider more complex demographic scenarios relevant to 218 changes, V A = V G for the additive model, and the variance explained by rare mutations depends primarily on 221 (S17 Fig) . For the GBR model, V A < V G (as in Fig 1) , and plateaus at the same ratio V A /V G for all time 222 points except immediately after the bottleneck, which results in a short-lived increase in V A /V G that is 223 undetectable by the time growth begins (S17 Fig) . All recessive models (GBR, iMR and cMR) may show a 224 transient increase in total V G after the bottleneck, depending on the value of (S18 Fig) . However, the GBR 225 and iMR models with h > 0.25 showed a return to constant population size levels by the final time point. The GREMLd and MS-HE estimates are accurate under the GBR model when is small, because most 254 heritability is additive in that case (Fig 1) . However, under the GBR model, both filtered and unfiltered 255 GREMLd heritability estimates show downward bias when is large (Fig 2) . The MS-HE regression results 256 reveal a similar pattern, which indicates that the downward bias for large values of is not strictly due to 9 removal of rare variants in the filtered GREMLd analysis. Instead, the bias shown for large values of is 258 likely due to the presence of substantial non-additive heritability, which is not captured by the dominance 259 effects of SNPs.
260
In contrast to the variance component methods, our simulated large twin studies provide approximately 261 unbiased estimates of total heritability for large values of , but were biased upward for small effect sizes 262 under the AC and GBR models (Fig 2) . The variance in twin-study estimates was large enough that 263 study-to-study disagreement would be expected. Formally, twin studies estimate an additive and a explanation is that we must assert that one of the study designs is generating artifacts.
277
The genetic model affects the outcomes of GWAS
278
Both demography and the model of gene action affect the degree to which rare variants contribute to the 279 genetic architecture of a trait (Fig 1) . However, the different mappings of genotype to phenotype from model 280 to model make it difficult to predict a priori the outcomes of GWAS under each model. Therefore, we sought 281 to explicitly examine the performance of statistical methods for GWAS under each genetic and demographic 282 model. We assessed the power of a single marker logistic regression to detect the gene region by calculating 283 the proportion of model replicates in which at least one variant reached genome wide significance at 284 ↵  10 8 ( Fig 3A) . The basic logistic regression is equivalent to testing for association under the AC model. 285 We simulated both a perfect "genotyping chip" (all markers with M AF 0.05) and complete re-sequencing 286 including all markers ( Fig 3B) .
287
Across all genetic models, the single marker logistic regression has less power under population expansion 288 ( Fig 3A) . The loss of power is attributable to a combination of rapid growth resulting in an excess of rare 289 variants overall [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] , and the increasing efficacy of selection against causal variants in growing 290 populations [21] . While complete resequencing is more powerful than a gene-chip design, the relative power 291 gained is modest under growth ( Fig 3A) . Region-based rare variant association tests behave similarly with 292 respect to population growth ( Fig 3B) .
293
There are important differences in the behavior of the examined statistical methods across genetic models. 294 We focus first on the single marker tests ( Fig 3A) . For gene-chip strategies, power increases for "site-based" 295 models as recessivity of risk variants increases (compare power for AC, iMR, and cMR models in Fig 3B) .
This increase in power is due to the well-known fact that recessive risk mutations are shielded from selection 297 when rare (due to being mostly present as heterozyogtes), thus reaching higher frequencies on average (S5 298 Fig) , and that the single-marker test is most powerful when risk variants are common [32] . Further, for the 299 complete multiplicative-recessive model (cMR), the majority of V G is due to common variants (Fig 1) , 300 explaining why resequencing does not increase power for this model (Fig 3A) . mutations are more rare with increasing lambda (S7 Fig). However, as a function of frequency, all V G may be 305 attributed to V A or V D in the site-specific models whereas there is increasing intralocus epistasis in the GBR 306 model as a function of (Fig 1) . It is well-known that the single marker test has lower power when causal 307 mutations have low frequencies, are poorly tagged by more common SNPs, or have small main effects [32, 71] . 308
Region-based rare variant association tests show many of the same patterns across genetic model and 309 effect size distribution as single marker tests, but there are some interesting differences. The ESM 310 test [36, 72] is the most powerful method tested for the AC, iMR, and GBR models (Fig 3b) , with the this model because there are not many marginally significant low-frequency markers. It is logical to think 320 that these tests would all perform better if all variants were included. The massive heterogeneity in the 321 performance of region-based rare variant tests across models strongly suggests that multiple methods should 322 be used when prior knowledge of underlying parameters is not available. In agreement with [22, 73], we 323 predict that population growth reduces the power to associate variants in a causal gene region with disease 324 status (Fig 3) when the disease also impacts evolutionary fitness. We have recently released software to apply 325 the ESM test to case control data [72] in order to facilitate applying this test to real data. 326 The distribution of minor allele frequencies of GWAS hits 327 It was noted by [4, 26] , that an excess of rare significant hits, relative to empirical data, is predicted by AC 328 models where large effect mutations contribute directly to fitness and the disease trait. We confirm that AC 329 models are inconsistent with the empirical data (Fig 4) , except when  0.01. The empirical data in Fig 4 330 represent a pooled data set with the same diseases and quality filters as in [26] , but updated to include more 331 recent data. The data are described in S1 Table, and can be visualized alone more clearly in S16 Fig. Close 332 to half of the data comes from GWAS studies uploaded to the NHGRI database after 2011, yet the same 333 qualitative pattern is observed. This contradicts the hypothesis that the initial observation of an excess of 334 common significant hits relative to the prediction under an AC model was simply due to small sample sizes 335 and low marker density in early GWAS previously analyzed in [4, 26] . Yet the initial observation is in fact 336 robust and the meta-pattern provides an appropriate point of comparison when considering the compatibility 337 of explicit population-genetic models with existing GWAS data.
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The GBR model predicts few rare significant hits and an approximately uniform distribution across the 339 remainder of MAF domain (Fig 4) , even for intermediate and large values of . For smaller values of , the 340 GBR predicts an excess of common significant hits. The more uniform distribution of significant single 341 markers seen under the GBR is consistent with the flatter distribution of genetic variance (Fig 1) . Under the 342 GBR results (Fig 4) . 349 We note that there is no compelling reason to expect any specific value of to be a particularly good fit 350 to the empirical data. The empirical data are composed of genome-wide data for multiple traits. We feel that 351 the mutational parameters, and mutation rate to causal variants, are likely to vary across the genome and 352 across traits. Thus, the empirical data reflect a mixture of different underlying models and ascertainment 353 schemes. The reason we emphasize this feature of the data is to demonstrate that models with rare alleles of 354 large effect do not necessarily imply an observed excess of rare significant GWAS hits.
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In consideration of the rare allele of large effect hypothesis, [62] proposed a model where multiple rare (Fig 4) . Models with loci of large 370 additive effects predict an excess of rare significant hits. Oppositely, models with complete site-based 371 recessivity predict an excess of common significant hits for all simulated mutation effect size distributions.
372
SNP based estimates of dominance heritability are much lower than estimates of dominance from 373 twins [27, 68] . Of the models we explored, only the gene-based recessive model with intermediate to large effects is consistent with difference between twin and SNP based estimates of dominance variance (Fig 2) . 375 Under a site-based recessive model of partial recessivity (e.g. h =0.25), there should be no significant 376 difference between estimates of dominance variance from SNP and twin studies, provided that the statistical 377 assumptions are met for both approaches (Fig 2) . Our findings support a more thorough investigation into 378 the importance of compound heterozygosity in the genetics complex-traits. However, it may be difficult to 379 directly observe non-additive gene-level effects through analysis of individual SNP markers. 380 Additionally, the genetic model appears to be important in the design and analysis of association studies. 381
While changes in population size do affect the relationship between effect size and mutation frequency [48-61] 382 (Fig 1 and S5 Fig) , different mappings of genotype to trait value do this in radically different ways for the 383 same demographic history (Fig 1) . From an empirical perspective, our findings suggest that re-sequencing in 384 large samples is likely the best way forward in the face of the allelic heterogeneity imposed by the presence of 385 rare alleles of large effect. Re-sequencing of candidate genes [76-79] and exomes [40, [80] [81] [82] [83] [84] [85] in case-control 386 panels have observed an abundance of rare variants associated with case status. Here we show that under a 387 model of mutation-selection balance at genes, neither current single-marker nor popular multi-marker tests 388 are especially powerful at detecting large genomic regions harboring multiple risk variants (Fig 3) more robust power across demographic and genetic models (Fig 3) . 392 Conceptually, cis-effects arise naturally from the original definition of a gene in which mutant recessive 393 alleles fail to complement [35] . We show that cis-effects within a locus, represented by the GBR model, can 394 have an important impact on the population level architecture of a complex trait. This conclusion is 395 important for future simulation studies as well as the interpretation of empirical data. It is important to note 396 that despite our use of the term "gene-based" this model may apply to any functional genomic element in 397 which there are multiple mutable sites affecting a trait in in cis, not just to genes. From a theoretical approximates a 100Kb region of the human genome. For simulations with growth, we simulated an additional 412 i = 2e4 to N final = 1e6. This demographic model is much 413 simpler than current models fit to empirical data [58] . However, this simple model allows us to more easily 414 get a sense of the impact of population expansion [21, 22] . 250 simulation trials were performed for each 415 parameter/model combination.
416
Exploring the gene region's contribution to heritability 417 Broad-sense heritability can be calculated directly from our simulated data as Determining the genetic load of the population 423 Genetic load is defined as the relative deviation in a populations fitness from the fitness optimum, 424 L = (w max w)/(w max ). We set the phenotypic optimum to be zero; P opt = 0. When determining fitness 425 for the SBR models, we subtract one from all phenotypes. This implies that w max = e P 2 opt 2 2 s = 1 and that 426 load is a simple function of the phenotypes of the population, L = 1 e P 2 2 2 s . We also used the mean number 427 of mutations per individual, and the mean frequency and effect sizes of segregating risk variants as proxies 428 for the genetic load [21, 90].
429
Additive and dominance genetic variance over allele frequency 430 We used an approach based sequential (type-1) regression sums of squares to estimate the contribution of the 431 additive and dominance effects of variants to the total genetic variation due to a locus. Given a genotype 432 matrix (rows are individuals and columns are risk variants) of (0,1, or 2) copies of a risk allele (e.g. all 433 mutations affecting phenotype), we sort the columns by decreasing risk mutation frequency. Then, within replicates, this procedure results in a Monte-Carlo estimate of the fraction of V G that is due to additive and 440 dominance effects of variants with population frequency less than or equal to x is
. This fraction can be easily partitioned into strictly additive and dominance 442 components. all non-additive heritability is due to dominance, then the dominance heritability can be calculated as twice 476 the difference between the MZ twin correlation and two-times the DZ twin correlation: computationally demanding, we applied the method in the generation immediately before, and at the start 527 of, any changes in population size.
528
These simulations were run with no neutral mutations, and the recombination rate and mutation rate to 529 causative mutations were the same as in the simulations described above. Table 1 . Description of parameters used in the models. 
